On Monday, Revolution Medicines Inc (NASDAQ: RVMD) trading session started at the price of On Monday, that was -3.17% drop from the session before settling in for the closing price of $37.87. A 52-week range for RVMD has been $29.17 – $62.40.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has dropped its sales by -27.80% annually for the last half of the decade. When this article was written, the company’s average yearly earnings per share was at -31.40%. With a float of $161.88 million, this company’s outstanding shares have now reached $186.26 million.
In an organization with 534 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 45.12%, operating margin of -301.78%, and the pretax margin is -266.93%.
Revolution Medicines Inc (RVMD) Insider Updates
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Revolution Medicines Inc stocks. The insider ownership of Revolution Medicines Inc is 13.09%, while institutional ownership is 93.56%. The most recent insider transaction that took place on Jun 20 ’25, was worth 75,736. In this transaction General Counsel of this company sold 1,912 shares at a rate of $39.61, taking the stock ownership to the 54,093 shares. Before that another transaction happened on Jun 20 ’25, when Company’s Officer proposed sale 1,912 for $39.93, making the entire transaction worth $76,346.
Revolution Medicines Inc (RVMD) Performance Highlights and Predictions
According to the Wall Street analysts, stocks earnings will be around -31.40% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -6.64% during the next five years compared to -27.80% drop over the previous five years of trading.
Revolution Medicines Inc (NASDAQ: RVMD) Trading Performance Indicators
You can see what Revolution Medicines Inc (RVMD) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 13.46.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -4.00, a number that is poised to hit -1.12 in the next quarter and is forecasted to reach -4.94 in one year’s time.
Technical Analysis of Revolution Medicines Inc (RVMD)
Let’s dig in a bit further. During the last 5-days, its volume was 2.22 million. That was better than the volume of 1.89 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 21.66%.
During the past 100 days, Revolution Medicines Inc’s (RVMD) raw stochastic average was set at 51.72%, which indicates a significant increase from 3.36% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 27.96% in the past 14 days, which was lower than the 50.04% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $39.49, while its 200-day Moving Average is $43.20. However, in the short run, Revolution Medicines Inc’s stock first resistance to watch stands at $37.52. Second resistance stands at $38.38. The third major resistance level sits at $38.87. If the price goes on to break the first support level at $36.17, it is likely to go to the next support level at $35.68. Assuming the price breaks the second support level, the third support level stands at $34.82.
Revolution Medicines Inc (NASDAQ: RVMD) Key Stats
There are 186,268K outstanding shares of the company, which has a market capitalization of 6.83 billion. As of now, sales total 0 K while income totals -600,090 K. Its latest quarter income was 0 K while its last quarter net income were -213,420 K.
